Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-04-16 | 2025-04-16 |
| Drug Identification Number | 02502623 | 02502623 |
| Brand name | ISOPROTERENOL HYDROCHLORIDE INJECTION USP | ISOPROTERENOL HYDROCHLORIDE INJECTION USP |
| Common or Proper name | ISOPROTERENOL HYDROCHLORIDE INJECTION USP | ISOPROTERENOL HYDROCHLORIDE INJECTION USP |
| Company Name | MARCAN PHARMACEUTICALS INC | MARCAN PHARMACEUTICALS INC |
| Ingredients | ISOPROTERENOL HYDROCHLORIDE | ISOPROTERENOL HYDROCHLORIDE |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 1MG/5ML (PACK 10 VIALS) | 1MG/5ML (PACK 10 VIALS) |
| ATC code | C01CA | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2025-04-15 | 2025-04-15 |
| Actual start date | 2025-04-15 | 2025-04-15 |
| Estimated end date | 2025-05-31 | 2025-05-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Isoproterenol 0.2mg/1mL pack is available as substitute | Isoproterenol 0.2mg/1mL pack is available as substitute |
| Health Canada comments |